Alliancebernstein L.P. Decreases Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Alliancebernstein L.P. decreased its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MDFree Report) by 9.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,350,489 shares of the company’s stock after selling 759,605 shares during the period. Alliancebernstein L.P. owned about 8.56% of Pediatrix Medical Group worth $96,438,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Nomura Asset Management Co. Ltd. lifted its holdings in shares of Pediatrix Medical Group by 95.3% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock valued at $33,000 after buying an additional 1,220 shares during the period. Parkside Financial Bank & Trust lifted its holdings in Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after acquiring an additional 1,040 shares during the period. Quarry LP boosted its position in Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after purchasing an additional 1,662 shares during the last quarter. AlphaQuest LLC grew its stake in shares of Pediatrix Medical Group by 65.9% during the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock valued at $66,000 after purchasing an additional 2,012 shares during the period. Finally, Smartleaf Asset Management LLC increased its position in shares of Pediatrix Medical Group by 750.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after purchasing an additional 6,090 shares during the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Price Performance

NYSE:MD opened at $14.83 on Thursday. The business’s 50-day simple moving average is $14.44 and its two-hundred day simple moving average is $13.75. Pediatrix Medical Group, Inc. has a 52 week low of $6.62 and a 52 week high of $17.67. The stock has a market cap of $1.27 billion, a PE ratio of -12.36, a P/E/G ratio of 1.74 and a beta of 1.49. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81.

Pediatrix Medical Group (NYSE:MDGet Free Report) last released its earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.37 by $0.12. The firm had revenue of $502.36 million for the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. As a group, analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

MD has been the subject of several recent research reports. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Truist Financial upped their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday, February 21st. UBS Group lifted their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research report on Friday, February 21st. Finally, Macquarie assumed coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They issued an “outperform” rating and a $18.00 price target for the company. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $17.08.

View Our Latest Report on Pediatrix Medical Group

About Pediatrix Medical Group

(Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Featured Articles

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MDFree Report).

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.